Related Experiment Videos
Circulating endothelin-1 levels in patients with bronchial asthma
Annals of Allergy
|October 1, 1994
Summary
Circulating endothelin-1 levels in asthma patients correlate with disease severity. Higher endothelin-1 indicates more severe asthma and bronchoconstriction, suggesting its potential as a biomarker.
Area of Science:
- Pulmonary Medicine
- Biochemistry
Background:
- Asthma is a chronic respiratory condition characterized by airway inflammation and hyperresponsiveness.
- Endothelin-1 is a potent vasoconstrictor peptide implicated in various cardiovascular and respiratory diseases.
Purpose of the Study:
- To investigate the association between plasma endothelin-1 levels and bronchial hyperreactivity in patients with asthma.
- To determine if endothelin-1 levels correlate with asthma severity and bronchoconstriction.
Main Methods:
- Plasma endothelin-1 levels were measured in 62 asthmatic patients during acute exacerbations.
- Pulmonary function tests, including FEV1/FVC ratio, were assessed in 17 patients.
- Changes in plasma endothelin-1 were monitored during methacholine inhalation challenges in 12 patients.
Main Results:
- Plasma endothelin-1 levels during acute asthma correlated significantly with the Clinical Asthma Evaluation Score.
- A significant negative correlation was found between plasma endothelin-1 levels and the FEV1/FVC ratio (P < .01).
- Endothelin-1 levels during methacholine challenge correlated with the degree of bronchoconstriction (P < .01).
Conclusions:
- Circulating endothelin-1 levels appear to reflect the severity of acute asthma.
- Endothelin-1 may play a role in the pathophysiology of asthma-related bronchoconstriction.
- Plasma endothelin-1 could serve as a potential biomarker for assessing asthma severity.